Roger Gunn

About

Roger Gunn serves as the Chief Science Officer at Xing Imaging, a Mitro Company, in the United Kingdom. His research focuses on advanced imaging techniques and neurophysiological dynamics, particularly in relation to Alzheimer's disease, Parkinson's disease, and the quantification of mitochondrial and synaptic function. Dr. Gunn has published extensively on topics including PET imaging reconstruction, dynamic nuclear polarisation, and integrin occupancy, contributing significantly to the fields of medical imaging and neuroscience.